Study population | Number (%) | Number (%) of adverse events (n = 43) |
|
With adverse events = 43 (26.2%) | 26 (15.9%) | Hypotension 26 (60.4%) |
|
8 (4.9%) | Bleeding 08 (18.7%) | Minor bleeding 08 (100%) | |
Major bleeding 00 (0%) | |||
7 (4.2%) | Allergic reaction 07 (16.3%) | Chills and rigor 04 (57.1%) | |
Erythema 02 (28.6%) | |||
Wheezing 01 (14.3%) | |||
Anaphylaxis 00 (0%) | |||
02 (1.2%) | Cardiac arrest 02 (4.6%) |
| |
No events | 121 (73.8%) |
|
|
Total | 164 (100%) |
|
|